ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 102 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2016. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $300,000 | -73.2% | 9,542 | -43.9% | 0.03% | +106.2% |
| Q4 2017 | $1,119,000 | -81.9% | 17,000 | -86.2% | 0.02% | -77.5% |
| Q3 2017 | $6,194,000 | +65.7% | 123,600 | +53.0% | 0.07% | +26.8% |
| Q2 2017 | $3,739,000 | -36.6% | 80,800 | -51.6% | 0.06% | -37.8% |
| Q1 2017 | $5,893,000 | +554.8% | 166,900 | +132.1% | 0.09% | +291.3% |
| Q4 2016 | $900,000 | +710.8% | 71,900 | +536.3% | 0.02% | +360.0% |
| Q2 2016 | $111,000 | -72.5% | 11,300 | -33.9% | 0.01% | -83.3% |
| Q3 2015 | $403,000 | -79.7% | 17,100 | -20.5% | 0.03% | -84.3% |
| Q1 2015 | $1,990,000 | – | 21,500 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |